［1］Benbaruch A.The multifaceted roles of chemokines in malignancy［J］.Cancer Metastasis Reviews，2006，25(3)：357.
［2］Ding H，Zhao L，Shan B.Expression and correlation of tumor-associated macrophages and CCL5 in ganstric cancer［J］.Chin J Immunol，2016(1)：74-78.
［3］Kalbasi A，Komar CA，Tooker GM，et al.Tumor-derived CCL2 mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma［J］.Clinical Cancer Research，2017，23(1)：137-148.
［4］Kersten K，Coffelt SB，Hoogstraat M，et al.Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophages［J］.Oncoimmunology，2017，6(8)：e1334744.
［5］He R，Yang X，Lin Y，et al.FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling［J］.Cancer Research，2016，76(14)：4124.
［6］Yi L，Zheng Y，Li T，et al.Chemokines CCL2，3，14 stimulate macrophage bone marrow homing，proliferation，and polarization in multiple myeloma［J］.Oncotarget，2015，6(27)：24218-24229.
［7］Wang Q，Tang Y，Yu H，et al.CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway［J］.Molecular Carcinogenesis，2016，55(11)：1688-1699.
［8］Liu Z，Li W，Zhang H，et al.CCL18/PITPNM3 enhances migration，invasion，and EMT through the NF-κB signaling pathway in hepatocellular carcinoma［J］.Tumor Biology，2016，37(3)：3461-3468.
［9］Zhu F，Li X，Chen S，et al.Tumor-associated macrophage or chemokine ligand CCL17 positively regulates the tumorigenesis of hepatocellular carcinoma［J］.Medical Oncology，2016，33(2)：1-12.
［10］Lee YS，Kim SY，Song SJ，et al.Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways［J］.Oncotarget，2016，7(24)：36842-36853.
［11］Selvan RS，Zhou LJ，Krangel MS.Regulation of I-309 gene expression in human monocytes by endogenous interleukin-1［J］.Eur J Immunol，2010，27(3)：687-694.
［12］Asano K，Kikuchi K，Tanaka M.CD169 macrophages regulate immune responses toward particulate materials in the circulating fluid［J］.Journal of Biochemistry，2018，164(2)：77-85.
［13］Bachmann MF，Kopf M，Marsland BJ.Chemokines：More than just road signs［J］.Nature Reviews Immunology，2006，6(2)：159-164.
［14］Damme JV，Proost P，Lenaerts JP，et al.Structural and functional identification of two human，tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family［J］.Journal of Experimental Medicine，1992，176(1)：59-65.
［15］Romagnani S.Cytokines and chemoattractants in allergic inflammation［J］.Molecular Immunology，2002，38(12-13)：881-885.
［16］Struyf S，Collie EV，Paemen L，et al.Synergistic induction of MCP-1 and-2 by IL-1beta and interferons in fibroblasts and epithelial cells［J］.Journal of Leukocyte Biology，1998，63(3)：364.
［17］Pype JL，Dupont LJ，Menten P，et al.Expression of monocyte chemotactic protein (MCP)-1，MCP-2，and MCP-3 by human airway smooth-muscle cells.Modulation by corticosteroids and T-helper 2 cytokines［J］.American Journal of Respiratory Cell & Molecular Biology，1999，21(4)：528-536.
［18］Rajaram M，Li J，Egeblad M，et al.System-wide analysis reveals a complex network of tumor-fibroblast interactions involved in tumorigenicity［J］.PLoS Genetics，2013，9(9)：e1003789.
［19］Gong X，Gong W，Kuhns DB，et al.Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors［J］.Journal of Biological Chemistry，1997，272(18)：11682-11685.
［20］Gong W，Howard OM，Turpin JA，et al.Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication［J］.Journal of Biological Chemistry，1998，273(8)：4289.
［21］Islam SA，Chang DS，Colvin RA，et al.Mouse CCL8，a CCR8 agonist，promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells［J］.Nature Immunology，2011，12(2)：167-177.
［22］Ge B，Li J，Wei Z，et al.Functional expression of CCL8 and its interaction with chemokine receptor CCR3［J］.Bmc Immunology，2017，18(1)：54.
［23］Debes GF，Diehl MC.CCL8 and skin T cells-an allergic attraction［J］.Nature Immunology，2011，12(2)：111-112.
［24］Dulek DE，Newcomb DC，Goleniewska K，et al.Allergic airway inflammation decreases lung bacterial burden following acute Klebsiella pneumoniae infection in a neutrophil-and CCL8-dependent manner［J］.Infection & Immunity，2014，82(9)：3723.
［25］Liu H，Liu Z，Chen J，et al.Induction of CCL8/MCP-2 by mycobacteria through the activation of TLR2/PI3K/Akt signaling pathway［J］.Plos One，2013，8(2)：e56815.
［26］van der Loo W，Afonso S，de Matos AL，et al.Pseudogenization of the MCP-2/CCL8 chemokine gene in European rabbit (genus Oryctolagus)，but not in species of Cottontail rabbit (Sylvilagus) and Hare (Lepus)［J］.BMC genetics，2012(13)：72.
［27］Johnston JB，Barrett JW，Chang W，et al.Role of the serine-threonine kinase PAK-1 in myxoma virus replication［J］.J Virol，2003，77(10)：5877.
［28］Cotterell SE，Engwerda CR，Kaye PM.Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani［J］.Infection & Immunity，2000，68(4)：1840-1848.
［29］Fioretti F，Fradelizi D，Stoppacciaro A，et al.Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer：Perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor［J］.J Immunol，1998，161(1)：342-346.
［30］Ota A，Yamamoto M，Hori T，et al.Upregulation of plasma CCL8 in mouse model of graft-vs-host disease［J］.Experimental Hematology，2009，37(4)：525-531.
［31］Lu Y，Jiang BC，Cao DL，et al.Chemokine CCL8 and its receptor CCR5 in the spinal cord are involved in visceral pain induced by experimental colitis in mice［J］.Brain Research Bulletin，2017(135)：170-178.
［32］Hayes LN，Severance EG，Leek JT，et al.Inflammatory molecular signature associated with infectious agents in psychosis［J］.Schizophrenia bulletin，2014，40(5)：963-972.
［33］FANG WY，SHEN LY，LI L，et al.Tumor-associated macrophages promote the development of papillary thyroid carcinoma through CCL8［C］.Compilation of Papers of the 11th National Endocrinology Academic Conference of Chinese Medical Association,2012:2012.
［34］Halvorsen EC，Hamilton MJ，Young A，et al.Maraviroc decreases CCL8-mediated migration of CCR5(+) regulatory T cells and reduces metastatic tumor growth in the lungs［J］.Oncoimmunology，2016，5(6)：e1150398.
［35］Barbai T，Fejs Z，Puskas LG，et al.The importance of microenvironment：The role of CCL8 in metastasis formation of melanoma［J］.Oncotarget，2015，6(30)：29111-29128.
［36］Farmaki E，Chatzistamou I，Kaza V，et al.A CCL8 gradient drives breast cancer cell dissemination［J］.Oncogene，2016，35(49)：6309-6318.
［37］Farmaki E，Chatzistamou I，Kaza V，et al.Abstract A26：A self-sustained gradient of CCL8 drives breast cancer metastasis［J］.Cancer Research，2016，76(7 Supplement)：A26.
［38］Torres S，Bartolomé RA，Mendes M，et al.Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer［J］.Clinical Cancer Research，2013，19(21)：6006-6019.
［39］Struyf S，Proost P，Vandercappellen J，et al.Synergistic up-regulation of MCP-2/CCL8 activity is counteracted by chemokine cleavage，limiting its inflammatory and anti-tumoral effects［J］.Eur J Immunol，2009，39(3)：843.
［40］Rom S，Rom I，Passiatore G，et al.CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells［J］.FASEB J，2010，24(7)：2292.
［41］Wetzel K，Menten P，Opdenakker G，et al.Transduction of human MCP-3 by a parvoviral vector induces leukocyte infiltration and reduces growth of human cervical carcinoma cell xenografts［J］.The Journal of Gene Medicine，2001，3(4)：326-337.
［42］Hiwatashi K，Tamiya T，Hasegawa E，et al.Suppression of SOCS3 in macrophages prevents cancer metastasis by modifying macrophage phase and MCP2/CCL8 induction［J］.Cancer Letters，2011，308(2)：172-180.
［43］Hintzen C，Haan C，Tuckermann J，et al.Oncostatin M-induced and constitutive activation of the JAK2/STAT5/CIS pathway suppresses CCL1，but not CCL7 and CCL8 chemokine expression［J］.Cell Communication & Signaling，2009，7(Suppl 1)：1.
［44］Yan C，Luo L，Urata Y，et al.Nicaraven reduces cancer metastasis to irradiated lungs by decreasing CCL8 and macrophage recruitment［J］.Cancer Lett，2018(418)：204-210.
［45］El Sissy C，Marliot F，Haicheur N，et al.Focus on the Immunoscore and its potential clinical implications［J］.Annales de pathologie，2017，37(1)：29-38.
［46］Galon J，Mlecnik B，Bindea G，et al.Towards the introduction of the 'Immunoscore' in the classification of malignant tumours［J］.J Pathol，2014，232(2)：199-209.
［47］Jiang Y，Zhang Q，Hu Y，et al.Immunoscore signature：a prognostic and predictive tool in gastric cancer［J］.Ann Surg，2018，267(3)：504-513.
［48］Mlecnik B，Bindea G，Angell HK，et al.Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability［J］.Immunity，2016，44(3)：698-711.
［49］Wang Y，Lin HC，Huang MY，et al.The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastases［J］.Cancer Immunology Immunotherapy：CII，2018，67(3)：435-444.